Murono S - Search Results

1

Siah-1 is associated with expression of hypoxia-inducible factor-1α in oral squamous cell carcinoma.

Aga M, Kondo S, Wakisaka N, Moriyama-Kita M, Endo K, Nakanishi Y, Murono S, Sugimoto H, Ueno T, Yoshizaki T. Aga M, et al. Among authors: murono s. Auris Nasus Larynx. 2017 Apr;44(2):213-219. doi: 10.1016/j.anl.2016.06.007. Epub 2016 Sep 8. Auris Nasus Larynx. 2017. PMID: 27616748

2

[Interaction between Epstein-Barr virus (EBV) gene expression and antibodies to EBV in nasopharyngeal carcinomas].

Furukawa M, Nagayama I, Murono S, Takeshita H, Nishimura T, Yoshizaki T. Furukawa M, et al. Among authors: murono s. Rinsho Byori. 1996 Sep;44(9):832-7. Rinsho Byori. 1996. PMID: 8911067 Japanese.

3

Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma.

Yoshizaki T, Sato H, Maruyama Y, Murono S, Furukawa M, Park CS, Seiki M. Yoshizaki T, et al. Among authors: murono s. Cancer. 1997 Jan 1;79(1):139-44. doi: 10.1002/(sici)1097-0142(19970101)79:1<139::aid-cncr20>3.0.co;2-4. Cancer. 1997. PMID: 8988738

4

[Detection of Epstein-Barr virus genomes in nasopharyngeal carcinoma].

Furukawa M, Murono S, Nakagawa S, Takeshita H, Yoshizaki T. Furukawa M, et al. Among authors: murono s. Nihon Rinsho. 1997 Feb;55(2):346-9. Nihon Rinsho. 1997. PMID: 9046821 Japanese.

5

Detection of Epstein-Barr virus in nasopharyngeal carcinoma by in situ hybridization and polymerase chain reaction.

Murono S, Yoshizaki T, Tanaka S, Takeshita H, Park CS, Furukawa M. Murono S, et al. Laryngoscope. 1997 Apr;107(4):523-6. doi: 10.1097/00005537-199704000-00017. Laryngoscope. 1997. PMID: 9111384

6

Association of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma.

Murono S, Yoshizaki T, Park CS, Furukawa M. Murono S, et al. Histopathology. 1999 May;34(5):432-8. doi: 10.1046/j.1365-2559.1999.00625.x. Histopathology. 1999. PMID: 10231418

7

Matrix metalloproteinase 9 is induced by the Epstein-Barr virus BZLF1 transactivator.

Yoshizaki T, Sato H, Murono S, Pagano JS, Furukawa M. Yoshizaki T, et al. Among authors: murono s. Clin Exp Metastasis. 1999 Jul;17(5):431-6. doi: 10.1023/a:1006699003525. Clin Exp Metastasis. 1999. PMID: 10651310

8

Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells.

Murono S, Inoue H, Tanabe T, Joab I, Yoshizaki T, Furukawa M, Pagano JS. Murono S, et al. Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6905-10. doi: 10.1073/pnas.121016998. Epub 2001 May 29. Proc Natl Acad Sci U S A. 2001. PMID: 11381123 Free PMC article.

9

Epstein-barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2.

Wakisaka N, Murono S, Yoshizaki T, Furukawa M, Pagano JS. Wakisaka N, et al. Among authors: murono s. Cancer Res. 2002 Nov 1;62(21):6337-44. Cancer Res. 2002. PMID: 12414666

10

Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.

Ren Q, Sato H, Murono S, Furukawa M, Yoshizaki T. Ren Q, et al. Among authors: murono s. Laryngoscope. 2004 May;114(5):855-9. doi: 10.1097/00005537-200405000-00012. Laryngoscope. 2004. PMID: 15126743

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112 results

Search Page

Filters